Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Inventory (2024 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Inventory for 2 consecutive years, with $4.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory rose 66.87% year-over-year to $4.1 million, compared with a TTM value of $4.1 million through Sep 2025, up 66.87%, and an annual FY2024 reading of $2.8 million, changed N/A over the prior year.
  • Inventory was $4.1 million for Q3 2025 at X4 Pharmaceuticals, up from $3.2 million in the prior quarter.
  • Across five years, Inventory topped out at $4.1 million in Q3 2025 and bottomed at $831000.0 in Q2 2024.